Loading

Please wait...

Terbinafine hcl

Generic Name: Terbinafine Cream and Gel (TER bin a feen)
Brand Name: Lamisil Advanced, Lamisil AT, Lamisil AT Athlete’s Foot, Lamisil AT Jock Itch
Easy-to-read patient leaflet for Lamisil Advanced. Includes indications, proper use, special instructions, precautions, and possible side effects.

Average Savings for terbinafine hcl (generic): 43.41%
  • Prescription Settings
  • X

Prices and coupons of Terbinafine hcl

Set your location
for drug prices near you

Enter your zip code

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
This medicine may interact with other drugs or health problems. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take Lamisil Advanced (terbinafine cream and gel) with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. Use Lamisil Advanced (terbinafine cream and gel) as ordered by your doctor. Read all information given to you. Follow all instructions closely. Learn more

Terbinafine hcl Side Effects

Terbinafine topical Side Effects

For the Consumer

Applies to terbinafine topical: topical cream, topical gel/jelly, topical spray

Along with its needed effects, terbinafine topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking terbinafine topical:

Rare

  • Dryness
  • redness
  • itching
  • burning
  • peeling
  • rash
  • stinging
  • tingling
  • or other signs of skin irritation not present before use of this medicine

For Healthcare Professionals

Applies to terbinafine topical: topical cream, topical gel, topical solution, topical spray

Dermatologic

Dermatologic side effects have included burning or irritation (1.3%), itching (1.1%), skin exfoliation (1%), and erythematous rash (0.9%).

General

Therapy was discontinued in clinical trials by 0.2% of patients treated with terbinafine solution and 0.6% of patients treated with placebo.

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.

Source: Drugs.com Terbinafine Hcl (www.drugs.com/terbinafine.html).